RNAC
Cartesian Therapeutics Inc.
7.40$
-2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +26.2% | -29.3% | +472.7% | -98.8% | -296.1% | – | -72.9% | +51.7% | +109.5% | -91.8% | -100.0% | – | |
| – | -99.1% | +50.0% | +7.1% | +45.9% | – | – | – | – | – | – | – | – | |
| – | – | -29.3% | +472.7% | -98.8% | -296.1% | – | -72.9% | -4,242.6% | – | -91.8% | – | – | |
| – | +72.5% | -56.6% | +30.0% | -10.0% | -0.8% | +29.8% | +1.3% | -7.2% | +6.4% | +32.5% | +5.0% | – | |
| – | +292.6% | -57.4% | -25.6% | -6.6% | +8.0% | +17.3% | -12.9% | -9.0% | +24.4% | -13.2% | +22.6% | – | |
| – | +574.3% | -57.0% | +2.6% | -8.8% | +44.6% | -11.5% | -3.8% | -60.6% | +162.4% | +16.1% | +9.7% | – | |
| – | – | – | – | -227.8% | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -274.8% | – | – | – | -326.0% | – | – | – | – | |
| – | -1,345.1% | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -274.8% | – | – | – | -326.0% | – | – | – | – | |
| – | – | – | – | -270.3% | – | – | – | -314.2% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.